TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,885,000 | -48.1% | 257,110 | -9.1% | 0.00% | -57.1% |
| Q3 2021 | $9,412,000 | -14.6% | 282,818 | -0.5% | 0.01% | -12.5% |
| Q2 2021 | $11,024,000 | -22.2% | 284,202 | -3.3% | 0.01% | -27.3% |
| Q1 2021 | $14,169,000 | -1.0% | 293,968 | +6.9% | 0.01% | 0.0% |
| Q4 2020 | $14,309,000 | +111.0% | 275,063 | +8.5% | 0.01% | +83.3% |
| Q3 2020 | $6,782,000 | +61.4% | 253,453 | +17.5% | 0.01% | +50.0% |
| Q2 2020 | $4,203,000 | +122.3% | 215,780 | +12.3% | 0.00% | +100.0% |
| Q1 2020 | $1,891,000 | -5.3% | 192,201 | +6.9% | 0.00% | 0.0% |
| Q4 2019 | $1,996,000 | +226.7% | 179,801 | +65.3% | 0.00% | +100.0% |
| Q3 2019 | $611,000 | -20.2% | 108,800 | +22.9% | 0.00% | 0.0% |
| Q2 2019 | $766,000 | +12.2% | 88,500 | +4.1% | 0.00% | 0.0% |
| Q1 2019 | $683,000 | +72.5% | 85,000 | -11.9% | 0.00% | 0.0% |
| Q4 2018 | $396,000 | -26.7% | 96,506 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $540,000 | -55.7% | 96,506 | +4.2% | 0.00% | -50.0% |
| Q2 2018 | $1,218,000 | -19.4% | 92,600 | -13.0% | 0.00% | 0.0% |
| Q1 2018 | $1,511,000 | +73.3% | 106,400 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $872,000 | -30.8% | 106,400 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,261,000 | +18.0% | 106,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,069,000 | -13.8% | 106,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,240,000 | +140.3% | 106,400 | -4.1% | 0.00% | +100.0% |
| Q4 2016 | $516,000 | -42.9% | 111,000 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $903,000 | +19.4% | 116,700 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $756,000 | -31.1% | 124,800 | -3.0% | 0.00% | -50.0% |
| Q1 2016 | $1,097,000 | -32.6% | 128,700 | -5.7% | 0.00% | -33.3% |
| Q4 2015 | $1,628,000 | -12.8% | 136,500 | -26.3% | 0.00% | 0.0% |
| Q3 2015 | $1,867,000 | -39.2% | 185,200 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $3,072,000 | +31.1% | 185,200 | +23.6% | 0.01% | +66.7% |
| Q1 2015 | $2,343,000 | 0.0% | 149,800 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,343,000 | +184.0% | 149,800 | +93.8% | 0.00% | +200.0% |
| Q3 2014 | $825,000 | +13.6% | 77,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $726,000 | +212.9% | 77,300 | +107.8% | 0.00% | – |
| Q1 2014 | $232,000 | +62.2% | 37,200 | 0.0% | 0.00% | – |
| Q4 2013 | $143,000 | -24.3% | 37,200 | 0.0% | 0.00% | – |
| Q3 2013 | $189,000 | – | 37,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |